Nuclear hormone receptor liver X receptor-alpha (LXRα) has a vital role in cholesterol homeostasis and is reported to have a role in adipose function and obesity although this is controversial. Conversely, mesenchymal stem cells (MSCs) are suggested to be a major source of adipocyte generation. Accordingly, we examined the role of LXRα in adipogenesis of MSCs. Adult murine MSCs (mMSCs) were isolated from wild-type (WT) and LXR-null mice. Using WT mMSCs, we further generated cell lines stably overexpressing GFP-LXRα (mMSC/LXRα/GFP) or GFP alone (mMSC/GFP) by retroviral infection. Confluent mMSCs were differentiated into adipocytes by the established protocol. Compared with MSCs isolated from WT mice, MSCs from LXR-null mice showed significantly increased adipogenesis, as determined by lipid droplet accumulation and adipogenesis-related gene expression. Moreover, mMSCs stably overexpressing GFP-LXRα (mMSC/LXRα/GFP) exhibited significantly decreased adipogenesis compared with mMSCs overexpressing GFP alone (mMSC/GFP). Since Wnt/beta-catenin signaling is reported to inhibit adipogenesis, we further examined it. The LXR-null group showed significantly decreased Wnt expression accompanied by a decrease of cellular beta-catenin (vs WT). The mMSC/LXRα/GFP group exhibited significantly increased Wnt expression accompanied by an increase of cellular beta-catenin (vs mMSC/ GFP). These data demonstrate that LXRα has an inhibitory effect on adipogenic differentiation in mMSCs with Wnt/betacatenin signaling. These results provide important insights into the pathophysiology of obesity and obesity-related consequences such as metabolic syndrome and may identify potential therapeutic targets.
Liver X receptor-alpha (LXRα) is an oxysterol-regulated nuclear hormone receptor and has a vital role in cholesterol and lipid homeostasis. [1] [2] [3] [4] [5] [6] [7] [8] [9] The expression of LXRα is restricted to tissues known to have important roles in lipid metabolism, such as the liver, adipose tissue, kidney, small intestine, skeletal muscle, and adrenal gland, whereas LXRβ is expressed ubiquitously. 1, 3, 4, 10 The functions of LXRs in liver have been studied extensively. A recent study demonstrated that an LXR agonist attenuated endotoxin-induced liver injury in high-fatdiet-induced hepatic steatosis in mice. 11 New evidence also points to an obesity-related effect of LXRs. Gao and Liu 12 reported that an LXR agonist protected mice against the development of high-fat diet-induced obesity. In addition, recent studies imply a role for LXRα in adipose tissue because of the following evidence. First of all, the expression of LXRα is high in adipocytes. 13 Second, the expression of LXRα is increased during adipogenesis. [14] [15] [16] Finally, the expression levels of many LXRα target genes are also high in adipocytes. 17 However, the role of LXRα in adipose tissue is not well defined. Interestingly, the role of LXRα in adipogenic differentiation is suggested by the studies using preadipocytes although those studies are limited and inconsistent. 14, 15 Obesity is one of the most important risk factors of metabolic syndrome. Severe obesity is associated with both an increase in adipose cell size and increased adipose cell number. [18] [19] [20] With respect to an increase in adipose cell number, mesenchymal stem cells (MSCs) are of note. Recent studies revealed that adult adipose tissue contains stem cells and they are much like bone marrow-derived MSCs. [21] [22] [23] In addition, Liechty et al 24 showed that human MSCs (hMSCs) transplanted into fetal sheep marrow differentiated and incorporated into normal adult adipose tissue. Moreover, Crossno et al 25 reported that adipocyte progenitor cells originating from bone marrow contribute to an increase in adipocyte number. Taken together, MSCs are suggested to be a major source of adipocyte generation; however, the effect of LXRα on MSC differentiation to adipocyte is unknown.
Wnt/beta-catenin signaling is one of the most important regulators of MSC fate. 26, 27 This signaling is also known to have a vital role in adipogenic differentiation of preadipocytes. 28, 29 Activation of Wnt/beta-catenin signaling blocks adipogenesis, [28] [29] [30] whereas inhibition of endogenous Wnt signaling promotes adipogenesis. 29, 31 Thus Wnt/betacatenin signaling is considered as a brake to adipogenic differentiation. Especially, Ross et al 29 reported that Wnt 10b is the most important endogenous regulator of adipogenesis.
In this study, we test our hypothesis that LXRα has an important role in adipogenic differentiation of MSCs. Our data demonstrate that the deletion of LXR accelerates adipogenesis and the overexpression of LXRα inhibits adipogenic differentiation. Furthermore, this inhibitory effect of LXRα on adipogenesis is associated with Wnt/beta-catenin signaling, which has a vital role to inhibit adipogenesis.
MATERIALS AND METHODS
Murine MSC (mMSC) Isolation and Culture All animal procedures were approved by the Duke University Institutional Animal Care and Use Committees. mMSCs were isolated by their adherence to plastic as previously described. [32] [33] [34] [35] [36] [37] [38] Bone marrow was collected from 12-weekold male LXRα/LXRβ double knock out (LXRKO) 39 and wild-type (WT) C57BL/6 mice by flushing femurs and tibias with the mMSC growth medium constituted of Minimum Essential Medium α (MEMα) with GlutaMAX (Invitrogen, Carlsbad, CA, USA), 20% fetal bovine serum (FBS), and penicillin/streptomycin (100 U/ml and 100 μg/ml, respectively). The bone marrow cells were then filtered through a 40-μm nylon mesh filter. Mononuclear cells were separated by gradient density using Ficoll-Paque Plus (Amersham Bioscience, Uppsala, Sweden). Cells were then washed twice with phosphate-buffered saline (PBS) and plated in plastic dishes. After 3 days, non-adherent cells were removed by two washes with PBS, and adherent cells were further cultured in the mMSC growth medium. Cells were then propagated in culture. Medium was changed every 3 days.
Confluent cells were incubated in adipogenic medium (Alpha-MEM-GlutaMax medium supplemented with 10 μg/ ml insulin, 0.1 μmol/l dexamethasone, 50 μmol/l 3-isobutyl-1-methyl-xanthine (IBMX), 20 μmol/l indomethacin, 20% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin) for 9 days. Medium was changed every 3 days. Cells were harvested at day 9 after the initiation of differentiation.
To quantitate adipocyte differentiation, AdipoRed Assay Reagent (Cambrex, Walkersville, MD, USA) was employed following the manufacturer's protocol. AdipoRed is a fluorescent dye that binds to lipid droplets. Total fluorescent signal was quantitated by fluorimeter.
Quantitative RT-PCR Total RNA was isolated by the Tri Reagent (Sigma) and further purified using RNeasy columns (Qiagen, Valencia, CA, USA). The concentration of RNA was determined using spectrophotometry. First-strand cDNA was synthesized from total RNA using the High Capacity cDNA Archive Kit (Applied Biosystems, Foster City, CA, USA) following the manufacturer's protocol. The Taqman probe primer system (Applied Biosystems) was used for quantitative RT-PCR. The primer and probe sets for murine peroxisome proliferatoractivated receptor-gamma (PPAR-gamma), fatty acid synthase (FAS), Wnt1, Wnt3a, Wnt5a, Wnt10b, and the housekeeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were purchased from Applied Biosystems. The primer and probe sets for human Wnt10b, LXRα, and GAPDH were also purchased from Applied Biosystems. TaqMan PCR was performed using ABI Prism 7700 Sequence Detection System as instructed by the manufacturer (Applied Biosystems). Target gene mRNA expression was normalized to GAPDH mRNA expression, and the relative amounts of all mRNAs were calculated using the comparative CT method. 40 Cell Lines Stably Overexpressing GFP or GFP-LXRα For the generation of mMSC lines stably expressing GFP or GFP-LXRα, LXRα cDNA was cloned into an MSCV-IRES-GFP plasmid backbone. Retroviral particles were then obtained by tripartite transfection in HEK 293T cells and concentrated by ultracentrifugation. WT C57BL/6 mMSCs were infected with retroviral particles in the presence of Polybrene (Sigma). Each infection was repeated twice. Pools of infected cells were then subcultured.
Immunoblotting
Cells were lysed at 4°C with RIPA Lysis Buffer (Upstate, Lake Placid, NY, USA). Equal amounts of proteins (20 μg per lane) were separated by NuPAGE 4-12% Bis-Tris Gel (Invitrogen) electrophoresis. Protein fractions were then electrophoretically transferred onto a polyvinylidene difluoride membrane. The membrane was blocked with Blocker/Diluent solution (Western Blot Kit, Invitrogen). Then the membrane was incubated with rabbit polyclonal antibody to human beta-catenin (Cell Signaling Technology, Danvers, MA, USA) for 1 h at room temperature. After washing in wash buffer (Western Blot Kit, Invitrogen), the membrane was incubated with horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (Western Blot Kit, Invitrogen) for 1 h at room temperature. The antigen antibody-peroxidase complex was visualized using the ECL chemiluminescence solution (Western Blot Kit, Invitrogen). The blot was subsequently stripped with Re-Blot Plus Western Blot Recycling Kit (Chemicon International, Temecula, CA, USA) and rehybridized with an anti-GAPDH antibody (Santa Cruz Biotechnology) as a control for protein loading. Densitometric quantitation was performed using the ImageJ software (NIH, Bethesda, MD, USA). Band intensity values of beta-catenin were standardized to those of GAPDH.
Analysis of Cellular Responses of hMSCs to LXR or Wnt
Ligand hMSCs were obtained from Cambrex. Cells were positive for CD105, CD166, CD29, and CD44 and negative for CD14, CD34, and CD45. hMSCs were grown in hMSC growth medium (Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 4 mmol/l L-glutamine, 100 units/ml penicillin, and 100 μg/ml streptomycin). The growth medium was changed every 3 days. The natural LXR agonist 22-hydroxycholesterol (22OH-C) was purchased from Sigma. Recombinant human Wnt1 protein was purchased from Abcam (Cambridge, MA, USA). Cells were subjected to serum depletion for 16 h. Then cells were exposed to 22OH-C (0.01 μmol/l) or vehicle for 6 h, after which Wnt10b mRNA expression was determined using quantitative RT-PCR. For analysis of Wnt ligand, cells were serum depleted for 16 h, as above, before being exposed to human recombinant Wnt1 protein (final concentration 20 ng/ml) or vehicle for 6 h. Cells were then harvested and total RNA was analyzed by quantitative RT-PCR to determine the LXRα mRNA expression.
Statistical Analysis
All statistical procedures were carried out using the Statgraphics Plus version 5.0 software (StatPoint, Herndon, VA, USA). Comparisons between the two groups were made using Student's t test, and the differences were considered to be significant when Po0.05.
RESULTS
Deletion of LXR Promotes Adipocyte Differentiation of mMSCs mMSCs were isolated from the bone marrow of WT and LXRKO mice. Cells were incubated in adipogenic medium (Alpha-MEM-GlutaMax medium supplemented with 10 μg/ ml insulin, 0.1 μmol/l dexamethasone, 50 μmol/l 3-isobutyl-1-methyl-xanthine (IBMX), 20 μmol/l indomethacin, 20% FBS, 100 U/ml penicillin, and 100 μg/ml streptomycin) for 9 days. As shown in Figure 1a , differentiated adipocytes exhibited lipid droplets in cytoplasm. AdipoRed fluorescent dye (Cambrex) was employed to stain lipid droplets (Figure 1b) . Adipogenesis was quantitated by measuring fluorescence using AdipoRed fluorescent dye. As shown in Figures 1c-e, lipid droplet accumulation was significantly greater in differentiated adipocytes from LXRKO mMSCs than those from the WT group (147.1 ± 24.9%; n = 12; Po0.05), suggesting an antiadipogenic effect of LXR on mMSCs.
Deletion of LXR Increases the Expression of Adipocyte-Related Genes
We also examined the expression of adipocyte-related genes by quantitative RT-PCR. mMSCs from WT and LXRKO mice were incubated in adipogenic medium for 9 days. Total RNA was analyzed by real-time RT-PCR for mRNA expression of PPAR-gamma and FAS on day 9. Consistent with the results regarding lipid droplet accumulation, PPAR-gamma and FAS expression was greater in the LXRKO compared with that in the WT group (2.33 ± 0.45-and 1.60 ± 0.24-fold increases, respectively; n = 4; Po0.05; Figures 2a and b) . 
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Overexpression of LXRα Inhibits Adipocyte Differentiation of mMSCs
We next generated mMSC cell lines stably expressing GFP-LXRα (mMSC/LXRα/GFP) by retroviral infection. Cell lines expressing GFP alone (mMSC/GFP) were also generated as control. Cells were incubated in adipogenic medium for 9 days.
Adipogenesis was quantitated by assessing lipid droplet accumulation using AdipoRed fluorescent dye. As shown in Figures 3a-c , lipid droplet accumulation was significantly lower in differentiated adipocytes from the mMSC/LXRα/ GFP group compared with that from the control mMSC/GFP group (59.2 ± 8.2%; n = 12; Po0.05), suggesting an antiadipogenic effect of LXRα on mMSCs.
Overexpression of LXRα Decreases the Expression of Adipocyte-Related Genes mMSCs overexpressing GFP alone (mMSC/GFP) and mMSCs overexpressing GFP-LXRα (mMSC/LXRα/GFP) were incubated in adipogenic medium for 9 days. Total RNA was analyzed by quantitative RT-PCR for mRNA expression of PPAR-gamma and FAS on day 9. Consistent with the results regarding lipid droplet accumulation, PPAR-gamma and FAS expression was decreased in the mMSC/LXRα/GFP group compared with that in the control mMSC/GFP group (0.75 ± 0.04-and 0.36 ± 0.02-fold changes vs the mMSC/ GFP group, respectively; n = 4; Po0.05; Figures 2c and d) .
Deletion of LXR Decreases Wnt Expression
As Wnt/beta-catenin signaling, especially Wnt 10b, is reported to inhibit adipogenesis, we examined the expression of Wnt genes by quantitative RT-PCR. mMSCs from WT and LXRKO mice were incubated in adipogenic medium for 9 days. Total RNA was analyzed by real-time RT-PCR for mRNA expression of Wnt1, Wnt3a, Wnt5a, and Wnt10b on day 9. As shown in Figures 4a-c , the LXRKO group showed a decreased expression of Wnt1, Wnt5a, and Wnt10b compared with that in the WT group (0.63 ± 0.14-, 0.54 ± 0.04-, and 0.25 ± 0.03-fold changes vs the WT group, respectively; n = 4; Po0.05). Especially, Wnt10b expression was remarkably decreased in the LXRKO group (Figure 4c ). Wnt 3a was not expressed in any samples (data not shown).
Deletion of LXR Decreases Cellular Beta-Catenin
To confirm the suppression of Wnt/beta-catenin signaling in the LXRKO group, we further examined cellular beta-catenin 
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protein expression by immunoblotting. mMSCs from WT and LXRKO mice were incubated in the adipogenic medium for 9 days. Cell lysates were isolated and subjected to immunoblotting analysis using antibodies for beta-catenin and GAPDH. As shown in Figure 4d , cellular beta-catenin protein expression was decreased in the LXRKO group compared with that in the WT group. Densitometric quantification from three independent experiments revealed that cellular beta-catenin protein expression was significantly suppressed in the LXRKO compared with that in the WT group (Figure 4e) , suggesting that the inhibitory effect of LXR on the adipogenesis of mMSCs is associated with Wnt/betacatenin signaling.
Overexpression of LXRα Increases Wnt Expression
We also examined the expression of Wnt genes in the mMSC/LXRα/GFP and mMSC/GFP groups by quantitative RT-PCR. mMSC/GFP and mMSC/LXRα/GFP were incubated in adipogenic medium for 9 days. Total RNA was analyzed by real-time RT-PCR for mRNA expression of Wnt1, Wnt3a, Wnt5a, and Wnt10b on day 9.
As shown in Figures 5a-c, the mMSC/LXRα/GFP group showed an increased expression of Wnt1, Wnt5a, and Wnt10b compared with that in the control mMSC/GFP group (3.45 ± 1.05-, 1.75 ± 0.14-, and 7.35 ± 0.90-fold increases, respectively; n = 4; Po0.05). Especially, Wnt10b expression was remarkably increased in the mMSC/LXRα/GFP group (Figure 5c ). Wnt3a was not expressed in any samples (data not shown).
Overexpression of LXRα Increases Cellular Beta-Catenin
To confirm the activation of Wnt/beta-catenin signaling in the mMSC/LXRα/GFP group, we examined cellular LXRα inhibits adipogenesis of stem cells K Matsushita et al beta-catenin protein expression by immunoblotting. mMSC/ GFP and mMSC/LXRα/GFP were incubated in the adipogenic medium for 9 days. Cell lysates were isolated and subjected to immunoblotting analysis using antibodies for beta-catenin and GAPDH. As shown in Figure 5d , cellular beta-catenin protein expression was increased in the mMSC/LXRα/GFP group compared with that in the control mMSC/GFP group. Densitometric quantification from three independent experiments revealed that cellular beta-catenin protein expression was increased significantly in the mMSC/LXRα/GFP compared with that in the control mMSC/GFP group (Figure 5e ). These results suggest that LXRα inhibits the adipogenesis of mMSCs in association with Wnt/beta-catenin signaling.
LXR Agonist 22-Hydroxycholesterol Upregulates Wnt10b Expression in hMSCs
Because an association between LXRα and Wnt/beta-catenin signaling was suggested in murine genetic models, we further examined cellular responses to LXR or Wnt ligand in hMSCs. After 16 h of serum depletion, hMSCs were exposed to 0.01 μmol/l 22OH-C for 6 h, and Wnt10b mRNA expression was evaluated using quantitative RT-PCR. As shown in Figure 6a , Wnt10b expression increased significantly in 22OH-C-treated hMSCs compared with that in vehicle-treated hMSCs (1.6 ± 0.2-fold increase; n = 3; Po0.05). Next, the effects of human recombinant Wnt1 protein (final concentration 20 ng/ml) on LXRα expression in hMSCs were evaluated. After 16 h of serum depletion and 6 h of exposure to 20 ng/ml human recombinant Wnt1 protein, there was no significant change in LXRα expression in hMSCs compared with vehicle treatment (Figure 6b ; 1.0 ± 0.1-fold change vs vehicle treatment; n = 3).
DISCUSSION
In this study, we have shown that the deletion of LXR accelerates adipogenesis and the overexpression of LXRα inhibits adipogenesis of mMSCs, demonstrating that LXRα has an inhibitory effect of adipogenesis of mMSCs. Furthermore, we have demonstrated that the inhibitory effect of LXRα on adipogenesis is associated with Wnt/beta-catenin signaling, which has a vital role to inhibit adipocyte LXRα inhibits adipogenesis of stem cells K Matsushita et al differentiation. Our data would suggest that the high level of expression of LXRα in adipose tissue 13 and the increase in LXRα mRNA levels during adipogenesis [14] [15] [16] contribute to the modulation of adipogenesis and obesity. Increased adiposity predisposes individuals to both type 2 diabetes and metabolic syndrome. Severe obesity is associated with both an increase in adipose cell size and increased adipose cell number. [18] [19] [20] Recent studies demonstrate that adipose tissue contains stem cells, much like bone marrow stromal MSCs. [21] [22] [23] New fat cells arise from a preexisting pool of adipose stem cells irrespective of age. 23, 41 In addition, Crossno et al 25 reported that adipocyte progenitor cells originating from bone marrow contribute to development of new adipocytes in adult animals. Taken together, MSCs are suggested to have an important role in the maintenance of mass and function of adult adipose tissue. Accordingly, in vitro differentiation of MSCs toward the adipogenic lineage provides a useful means for studying in tissue culture the regulation of adipogenesis. 42, 43 Nuclear hormone receptor LXRα has a vital role to control lipid and cholesterol homeostasis. [1] [2] [3] [4] [5] [6] [7] [8] [9] The roles of LXRα in the liver and in macrophages have been studied extensively. In a recent study, an LXR agonist attenuated endotoxin-induced liver injury in high-fat-diet-induced hepatic steatosis in mice. 11 In addition, Gao and Liu 12 reported that an LXR agonist protected mice against the development of high-fat-dietinduced obesity. With regard to the relationship between adipocytes and cholesterol, adipocytes contain the largest pool of free cholesterol in the body, 44 and recent studies have demonstrated high levels of LXRα expression in adipocytes, 13 increased LXRα mRNA levels during adipogenesis [14] [15] [16] and high levels of expression of many LXRα target genes in adipocytes. 17 However, the role of LXRα in adipose tissue is not well defined. Despite the fact that the expression of LXRα increases during adipogenesis, the role of LXRα in adipose differentiation has remained conflicting. The studies using preadipocytes reported the function of LXRα as both positive and negative regulator of adipocyte differentiation. 14, 15 Ross et al 15 have reported that LXR activity inhibits adipocyte differentiation and lipid accumulation in cultured preadipocytes. They showed that ectopic expression of a constitutively active VP16-LXR-alpha fusion protein inhibited the differentiation of preadipocytes 3T3-L1 cells. In contrast to Ross et al, 15 Juvet et al 14 reported that LXR agonist treatment of differentiating adipocytes led to increased lipid accumulation. Our observation that LXRα has inhibitory effects on adipogenesis is consistent with the former report. These inconsistent data may reflect differences in cell types, cell line variations, and culture conditions. In this study, we used MSCs instead of preadipocytes. Developmentally, MSCs are at the step between the undifferentiated multipotent embryonic stem cells and the preadipocytes. [45] [46] [47] [48] Our data could suggest the effect of LXRα on the first step of adipogenesis.
Importantly, Beaven et al 49 recently reported that LXRKO mice, when bred onto the OB background (ob/ob LXRαβ − / − mice), exhibited increased total body adiposity compared with OB mice. Conversely, LXRKO mice are likely to be protected against diet-induced obesity through increased energy expenditure. 50 However, adipose tissue-specific LXR-null mice have not yet been generated. Therefore, it is difficult to identify the precise roles of LXR in adipose tissue. Future studies are needed to elucidate the involvement of LXR in adipocyte differentiation and adipose biology.
We also studied the mechanism of the inhibitory effect of LXRα on adipogenesis of MSCs. Wnt/beta-catenin signaling is reported to be an important regulator of MSC fate. 26, 27 This signaling is also known to have a vital role in adipogenic differentiation of preadipocytes. 28, 29 Activation of Wnt/betacatenin signaling blocks adipogenesis. [28] [29] [30] On the other hand, inhibition of endogenous Wnt signaling is reported to promote adipogenesis. 29, 31 Therefore, Wnts are considered as a brake to adipogenic differentiation. In particular, Ross et al 29 reported that Wnt10b is the most important endogenous regulator of adipogenesis. Longo et al 30 created transgenic mice in which Wnt10b is expressed from the FABP4 promoter (FABP4-Wnt10b mice) and found that these mice had reduced adiposity and were resistant to diet-induced obesity. In addition, Wright et al 51 reported that expression of Wnt10b in adipose tissue reduces adiposity in the ob/ob obesity model. Those authors also reported that Wnt10b protected against genetic obesity in mice owing to ectopic expression of agouti (A y ). 51 In this study, the deletion of LXR decreases Wnt1, Wnt5a, and Wnt10b expression. Especially, Wnt10b expression is remarkably decreased. Moreover, the deletion of LXR decreases cellular betacatenin protein expression, confirming that Wnt/beta-catenin signaling is suppressed. Consistent with the data of LXR The results of the present study suggest that the mechanism underlying the inhibitory effect of LXRα on the adipogenesis of MSCs is associated with Wnt/beta-catenin signaling. Furthermore, the data suggest that the action may be LXR ligand dependent. However, the precise mechanisms underlying the association between LXRα and Wnt/betacatenin signaling remain unclear. Whether LXRα acts as a heterodimer or not and the role of LXRβ are unknown. In addition, there are a number of molecules that regulate adipogenesis, even though Wnt/beta-catenin signaling has been suggested as one of the most important pathways. Therefore, further experiments are needed to elucidate the mechanism(s) underlying the antiadipogenic effect of LXRα more clearly.
In conclusion, the present study demonstrates that LXRα inhibits adipocyte differentiation of mMSCs with Wnt/beta-catenin signaling. Such a role of LXRα might be physiologically important in the maintenance of the mass and function of adult adipose tissue. Our results support a role for LXRα in adipose tissue, and further characterization of the role of LXRα in adipocyte biology is important for future research on obesity, with possible therapeutic implications for treatment of obesity and obesity-related consequences, such as metabolic syndrome.
